Use of Immunosuppressants/Immunomodulators in Autoimmune/Inflammatory Dermatologic Diseases during COVID-19 Pandemic-General Recommendation Based on Available Evidence.

作者: Deepika Pandhi , Dipankar De

DOI: 10.4103/IDOJ.IDOJ_414_20

关键词:

摘要:

参考文章(31)
A. V. Marzano, A. Tedeschi, I. Polloni, C. Crosti, M. Cugno, Prothrombotic state and impaired fibrinolysis in bullous pemphigoid, the most frequent autoimmune blistering disease. Clinical and Experimental Immunology. ,vol. 171, pp. 76- 81 ,(2013) , 10.1111/J.1365-2249.2012.04674.X
R. M. Zinkernagel, Immunology taught by viruses Science. ,vol. 271, pp. 173- 178 ,(1996) , 10.1126/SCIENCE.271.5246.173
S Sorbara, E Cozzani, A Rebora, A Parodi, Hydroxychloroquine in psoriasis: is it really harmful? Acta Dermato-venereologica. ,vol. 86, pp. 450- 451 ,(2006) , 10.2340/00015555-0141
Karen E. Harman, Takashi Hashimoto, Michael Hertl, Nico Hunzelmann, Pilar Iranzo, Pascal Joly, Marcel F. Jonkman, Yasuo Kitajima, Neil J. Korman, Linda K. Martin, Daniel Mimouni, Amit G. Pandya, Aimee S. Payne, David Rubenstein, Hiroshi Shimizu, Animesh A. Sinha, David Sirois, Detlef Zillikens, Victoria P. Werth, Dedee F. Murrell, Sarah Dick, A.R. Ahmed, Masayuki Amagai, Maria A. Barnadas, Luca Borradori, Jean-Claude Bystryn, Giuseppe Cianchini, Luis Diaz, David Fivenson, Russell Hall, Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus Journal of the American Academy of Dermatology. ,vol. 58, pp. 1043- 1046 ,(2008) , 10.1016/J.JAAD.2008.01.012
Paolo Bucciarelli, Ylenia Balice, Giuseppe Cianchini, Pietro Quaglino, Piergiacomo Calzavara Pinton, Marzia Caproni, Mauro Alaibac, Clara De Simone, Annalisa Patrizi, Emanuele Cozzani, Manuela Papini, Alberto Tedeschi, Emilio Berti, Frits R. Rosendaal, Massimo Cugno, Angelo V. Marzano, , Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study Thrombosis and Haemostasis. ,vol. 115, pp. 193- 199 ,(2015) , 10.1160/TH15-04-0309
Antonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno, Martin Aringer, Ingeborg Bajema, John N Boletis, Ricard Cervera, Andrea Doria, Caroline Gordon, Marcello Govoni, Frédéric Houssiau, David Jayne, Marios Kouloumas, Annegret Kuhn, Janni L Larsen, Kirsten Lerstrøm, Gabriella Moroni, Marta Mosca, Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Vladimir Tesar, Angela Tincani, Anne Troldborg, Ronald Van Vollenhoven, Jörg Wenzel, George Bertsias, Dimitrios T Boumpas, None, 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Annals of the Rheumatic Diseases. ,vol. 78, pp. 736- 745 ,(2019) , 10.1136/ANNRHEUMDIS-2019-215089
Zhiyong Peng, Xinghuan Wang, Yong Xiong, Yirong Li, Jing Zhang, Bo Hu, Chang Hu, Dawei Wang, Hui Xiang, Xing Liu, Fangfang Zhu, Binbin Wang, Zhenshun Cheng, Yan Zhao, Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. ,vol. 323, pp. 1061- 1069 ,(2020) , 10.1001/JAMA.2020.1585
Lisheng Wang, Yiru Wang, Dawei Ye, Qingquan Liu, Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. International Journal of Antimicrobial Agents. ,vol. 55, pp. 105948- ,(2020) , 10.1016/J.IJANTIMICAG.2020.105948
Wei Cao, Xiaosheng Liu, Tao Bai, Hongwei Fan, Ke Hong, Hui Song, Yang Han, Ling Lin, Lianguo Ruan, Taisheng Li, High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with Coronavirus Disease 2019 Open Forum Infectious Diseases. ,vol. 7, pp. 1- 6 ,(2020) , 10.1093/OFID/OFAA102
Mark Lebwohl, Ryan Rivera-Oyola, Dedee F. Murrell, Should biologics for psoriasis be interrupted in the era of COVID-19? Journal of The American Academy of Dermatology. ,vol. 82, pp. 1217- 1218 ,(2020) , 10.1016/J.JAAD.2020.03.031